Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib
Titel:
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib
Auteur:
Vallez-Valero, Lucía Gasó-Gago, Ingrid Marcos-Fendian, Ángel Garrido-Alejos, Gemma Riera-Magallón, Adrià Plaza Diaz, Adrián Martinez-Molina, Cristina Mangues-Bafalluy, Maria Antònia Corominas, Hèctor